Personalized medicine—and personalized vaccines, in particular—have generated tremendous interest. Each vaccine must be custom-made for each patient, so for each patient more work must be done than is required for “off-the-shelf” vaccines. What are needed now are methods that enable the manufacture of such products in an affordable and efficient manner.
I’m a big fan of the singer Jack Johnson and for some reason I’ve recently had the song Inaudible Melodies in my head. The song references a story about martial artist Bruce Lee, who apparently moved so quickly that a director for one of his early films asked him to slow down. The reasoning was that he was moving faster than the individual film frames in the camera and that made his action look blurry, or out of focus. The song chorus goes like this:
GENEVA—The Drugs for Neglected Diseases Initiative (DNDi) received a €9.5-million grant from the United Kingdom’s Department of International Development (DFID)for development of drugs for tropical diseases
MALVERN, Penn.—Novavax announced a collaborative agreement with the University of Pittsburgh School of Medicine to evaluate virus-like particle (VLP) influenza vaccines and the Novasome delivery adjuvant
BREMEN, Germany—MS specialist Bruker Daltonik announced a collaboration with the German Collection of Microorganisms and Cell Cultures (DSMZ) to identify and classify microbes from their proteomic profiles